Restricted accessResearch articleFirst published online 2020-12
Low-density lipoprotein cholesterol target value attainment based on 2019 ESC/EAS guidelines and lipid-lowering therapy titration for patients with acute coronary syndrome
TownsendNWilsonLBhatnagarP, et al.Cardiovascular disease in Europe: Epidemiological update 2016. Eur Heart J2016; 37: 3232–3245.
2.
BuenoHMartín AsenjoR. Long-term cardiovascular risk after acute coronary syndrome, an ongoing challenge. Rev Española Cardiol (English Ed)2016; 69: 1–2.
3.
Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. Eur Heart J. Epub ahead of print 31 August 2019. DOI: 10.1093/eurheartj/ehz455.
4.
Boulmpou A, Kartas A, Farmakis I, et al. Motivational interviewing to support LDL-C therapeutic goals and lipid-lowering therapy compliance in patients with acute coronary syndromes (IDEAL-LDL) study: Rationale and design. Hell J Cardiol. Epub ahead of print 21 October 2018. DOI: 10.1016/j.hjc.2018.10.002.
5.
Farmakis I, Zafeiropoulos S, Kartas A, et al. Treatment practices and lipid profile of patients with acute coronary syndrome: Results from a tertiary care hospital. Acta Cardiol. Epub ahead of print 20 June 2019. DOI: 10.1080/00015385.2019.1626087.
6.
WengT-CYangY-HKLinS-J, et al.A systematic review and meta-analysis on the therapeutic equivalence of statins. J Clin Pharm Ther2010; 35: 139–151.
7.
De BackerGFrasZ, et al.Reiner. Lipid lowering drug therapy in patients with coronary heart disease from 24 European countries – findings from the EUROASPIRE IV survey. Atherosclerosis2016; 246: 243–50.
8.
FerrieresJDe FerrariGMHermansMP, et al.Predictors of LDL-cholesterol target value attainment differ in acute and chronic coronary heart disease patients: Results from DYSIS II Europe. Eur J Prev Cardiol2018; 25: 1966–1976.
9.
ZafrirBSalibaWJaffeR, et al.Attainment of lipid goals and long-term mortality after coronary-artery bypass surgery. Eur J Prev Cardiol2019; 26: 401–408.
10.
WangWTHellkampADollJA, et al.Lipid testing and statin dosing after acute myocardial infarction. J Am Heart Assoc2018; 7: e006460–e006460.
11.
De VeraMABholeVBurnsLC, et al.Impact of statin adherence on cardiovascular disease and mortality outcomes: A systematic review. Br J Clin Pharmacol2014; 78: 684–698.
12.
RobinsonJGHuijgenRRayK, et al.Determining when to add nonstatin therapy: A quantitative approach. J Am Coll Cardiol2016; 68: 2412–2421.
13.
SchwaabBZeymerUJannowitzC, et al.Improvement of low-density lipoprotein cholesterol target achievement rates through cardiac rehabilitation for patients after ST elevation myocardial infarction or non-ST elevation myocardial infarction in Germany: Results of the PATIENT CARE registry. Eur J Prev Cardiol2019; 26: 249–258.
